BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1437337)

  • 1. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
    Pfenninger J; Aebi C; Bachmann D; Wagner BP
    Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
    Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
    Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
    Cotton RB; Olsson T; Law AB; Parker RA; Lindstrom DP; Silberberg AR; Sundell HW; Sandberg K
    Pediatr Res; 1993 Oct; 34(4):495-501. PubMed ID: 8255684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
    Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
    Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
    Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory mechanics before and after late artificial surfactant rescue.
    Todd DA; Choukroun ML; Fayon M; Kays C; Guénard H; Galpérine I; Demarquez JL
    J Paediatr Child Health; 1995 Dec; 31(6):532-6. PubMed ID: 8924306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
    Bhutani VK; Abbasi S; Long WA; Gerdes JS
    J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
    da Costa DE; Pai MG; Al Khusaiby SM
    Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.
    Armsby DH; Bellon G; Carlisle K; Rector D; Baldwin R; Long W; Stevenson DK; Ariagno RL
    Pediatr Pulmonol; 1992 Dec; 14(4):206-13. PubMed ID: 1484754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
    Malathi I; Ng KC
    Ann Acad Med Singap; 1995 Nov; 24(6):781-4. PubMed ID: 8838980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial surfactant attenuates hyperoxic lung injury in primates. I. Physiology and biochemistry.
    Huang YC; Sane AC; Simonson SG; Fawcett TA; Moon RE; Fracica PJ; Menache MG; Piantadosi CA; Young SL
    J Appl Physiol (1985); 1995 May; 78(5):1816-22. PubMed ID: 7649917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary mechanics in premature infants one month after treatment with synthetic surfactant.
    Goldman SL; Bosque E; McCann E; Lewis K
    J Pediatr; 1992 Feb; 120(2 Pt 2):S25-8. PubMed ID: 1735847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
    Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
    J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
    Phibbs RH; Ballard RA; Clements JA; Heilbron DC; Phibbs CS; Schlueter MA; Sniderman SH; Tooley WH; Wakeley A
    Pediatrics; 1991 Jul; 88(1):1-9. PubMed ID: 2057244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome.
    Sandberg KL; Lindstrom DP; Sjöqvist BA; Parker RA; Cotton RB
    Pediatr Pulmonol; 1997 Nov; 24(5):337-43. PubMed ID: 9407567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
    Horbar JD; Wright LL; Soll RF; Wright EC; Fanaroff AA; Korones SB; Shankaran S; Oh W; Fletcher BD; Bauer CR
    J Pediatr; 1993 Nov; 123(5):757-66. PubMed ID: 8229487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
    J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.
    Billman D; Nicks J; Schumacher R
    Pediatr Pulmonol; 1994 Nov; 18(5):279-83. PubMed ID: 7898965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.